Clinical Trial Update: Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of Alginos Oral Suspension for laryngopharyngeal reflux has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngopharyngeal Reflux

Drugs mentioned

• Alginos Oral Suspension

Snippet

Sponsor: TTY Biopharm | Conditions: Laryngopharyngeal Reflux | Phase 3 | Status: COMPLETED